1 Ultra-low Molecular Weight Heparin (ULMWH) Market Overview 1.1 Product Overview and Scope of Ultra-low Molecular Weight Heparin (ULMWH) 1.2 Ultra-low Molecular Weight Heparin (ULMWH) Segment by Type 1.2.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Oral 1.2.3 Parenteral 1.3 Ultra-low Molecular Weight Heparin (ULMWH) Segment by Application 1.3.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Comparison by Application: (2022-2028) 1.3.2 Treatment of Venous Thromboembolism 1.3.3 Complications of Pregnancy 1.3.4 Cardioversion of Atrial Fibrillation/Flutter 1.4 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size Estimates and Forecasts 1.4.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue 2017-2028 1.4.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales 2017-2028 1.4.3 Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ultra-low Molecular Weight Heparin (ULMWH) Market Competition by Manufacturers 2.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ultra-low Molecular Weight Heparin (ULMWH) Manufacturing Sites, Area Served, Product Type 2.5 Ultra-low Molecular Weight Heparin (ULMWH) Market Competitive Situation and Trends 2.5.1 Ultra-low Molecular Weight Heparin (ULMWH) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ultra-low Molecular Weight Heparin (ULMWH) Players Market Share by Revenue 2.5.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ultra-low Molecular Weight Heparin (ULMWH) Retrospective Market Scenario by Region 3.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ultra-low Molecular Weight Heparin (ULMWH) Market Facts & Figures by Country 3.3.1 North America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country 3.3.2 North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ultra-low Molecular Weight Heparin (ULMWH) Market Facts & Figures by Country 3.4.1 Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country 3.4.2 Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Market Facts & Figures by Region 3.5.1 Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region 3.5.2 Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ultra-low Molecular Weight Heparin (ULMWH) Market Facts & Figures by Country 3.6.1 Latin America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country 3.6.2 Latin America Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Market Facts & Figures by Country 3.7.1 Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country 3.7.2 Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Ultra-low Molecular Weight Heparin (ULMWH) Historic Market Analysis by Type 4.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2017-2022) 4.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Type (2017-2022) 4.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Price by Type (2017-2022) 5 Global Ultra-low Molecular Weight Heparin (ULMWH) Historic Market Analysis by Application 5.1 Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2017-2022) 5.2 Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Application (2017-2022) 5.3 Global Ultra-low Molecular Weight Heparin (ULMWH) Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Hepalink 6.1.1 Hepalink Corporation Information 6.1.2 Hepalink Description and Business Overview 6.1.3 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.1.5 Hepalink Recent Developments/Updates 6.2 Changshan Pharm 6.2.1 Changshan Pharm Corporation Information 6.2.2 Changshan Pharm Description and Business Overview 6.2.3 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.2.5 Changshan Pharm Recent Developments/Updates 6.3 Qianhong Bio-pharma 6.3.1 Qianhong Bio-pharma Corporation Information 6.3.2 Qianhong Bio-pharma Description and Business Overview 6.3.3 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.3.5 Qianhong Bio-pharma Recent Developments/Updates 6.4 Opocrin 6.4.1 Opocrin Corporation Information 6.4.2 Opocrin Description and Business Overview 6.4.3 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.4.5 Opocrin Recent Developments/Updates 6.5 Pfizer 6.5.1 Pfizer Corporation Information 6.5.2 Pfizer Description and Business Overview 6.5.3 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.5.5 Pfizer Recent Developments/Updates 6.6 Aspen Oss 6.6.1 Aspen Oss Corporation Information 6.6.2 Aspen Oss Description and Business Overview 6.6.3 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.6.5 Aspen Oss Recent Developments/Updates 6.7 King-friend Biochemical Pharmaceutical 6.6.1 King-friend Biochemical Pharmaceutical Corporation Information 6.6.2 King-friend Biochemical Pharmaceutical Description and Business Overview 6.6.3 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.4.4 King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.7.5 King-friend Biochemical Pharmaceutical Recent Developments/Updates 6.8 Bioiberica 6.8.1 Bioiberica Corporation Information 6.8.2 Bioiberica Description and Business Overview 6.8.3 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.8.5 Bioiberica Recent Developments/Updates 6.9 Dongcheng Biochemicals 6.9.1 Dongcheng Biochemicals Corporation Information 6.9.2 Dongcheng Biochemicals Description and Business Overview 6.9.3 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.9.5 Dongcheng Biochemicals Recent Developments/Updates 6.10 Jiulong Biochemicals 6.10.1 Jiulong Biochemicals Corporation Information 6.10.2 Jiulong Biochemicals Description and Business Overview 6.10.3 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.10.5 Jiulong Biochemicals Recent Developments/Updates 6.11 Tiandong 6.11.1 Tiandong Corporation Information 6.11.2 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Description and Business Overview 6.11.3 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.11.5 Tiandong Recent Developments/Updates 6.12 Xinbai 6.12.1 Xinbai Corporation Information 6.12.2 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Description and Business Overview 6.12.3 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.12.5 Xinbai Recent Developments/Updates 6.13 Yino Pharma Limited 6.13.1 Yino Pharma Limited Corporation Information 6.13.2 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Description and Business Overview 6.13.3 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.13.5 Yino Pharma Limited Recent Developments/Updates 6.14 Deebio 6.14.1 Deebio Corporation Information 6.14.2 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Description and Business Overview 6.14.3 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Deebio Ultra-low Molecular Weight Heparin (ULMWH) Product Portfolio 6.14.5 Deebio Recent Developments/Updates 7 Ultra-low Molecular Weight Heparin (ULMWH) Manufacturing Cost Analysis 7.1 Ultra-low Molecular Weight Heparin (ULMWH) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ultra-low Molecular Weight Heparin (ULMWH) 7.4 Ultra-low Molecular Weight Heparin (ULMWH) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ultra-low Molecular Weight Heparin (ULMWH) Distributors List 8.3 Ultra-low Molecular Weight Heparin (ULMWH) Customers 9 Ultra-low Molecular Weight Heparin (ULMWH) Market Dynamics 9.1 Ultra-low Molecular Weight Heparin (ULMWH) Industry Trends 9.2 Ultra-low Molecular Weight Heparin (ULMWH) Market Drivers 9.3 Ultra-low Molecular Weight Heparin (ULMWH) Market Challenges 9.4 Ultra-low Molecular Weight Heparin (ULMWH) Market Restraints 10 Global Market Forecast 10.1 Ultra-low Molecular Weight Heparin (ULMWH) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ultra-low Molecular Weight Heparin (ULMWH) by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ultra-low Molecular Weight Heparin (ULMWH) by Type (2023-2028) 10.2 Ultra-low Molecular Weight Heparin (ULMWH) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ultra-low Molecular Weight Heparin (ULMWH) by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ultra-low Molecular Weight Heparin (ULMWH) by Application (2023-2028) 10.3 Ultra-low Molecular Weight Heparin (ULMWH) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ultra-low Molecular Weight Heparin (ULMWH) by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ultra-low Molecular Weight Heparin (ULMWH) by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million) Table 2. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million) Table 3. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses) of Key Manufacturers (2017-2022) Table 6. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ultra-low Molecular Weight Heparin (ULMWH) Average Price (USD/Dose) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ultra-low Molecular Weight Heparin (ULMWH) Manufacturing Sites and Area Served Table 11. Manufacturers Ultra-low Molecular Weight Heparin (ULMWH) Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ultra-low Molecular Weight Heparin (ULMWH) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ultra-low Molecular Weight Heparin (ULMWH) as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region (2017-2022) & (K Doses) Table 16. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Region (2017-2022) Table 17. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2017-2022) Table 19. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2017-2022) & (K Doses) Table 20. North America Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2017-2022) Table 21. North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Country (2017-2022) Table 23. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2017-2022) & (K Doses) Table 24. Europe Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2017-2022) Table 25. Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales by Region (2017-2022) & (K Doses) Table 28. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2017-2022) Table 31. Latin America Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2017-2022) & (K Doses) Table 32. Latin America Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2017-2022) Table 33. Latin America Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales by Country (2017-2022) & (K Doses) Table 36. Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Country (2017-2022) Table 39. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales by Type (2017-2022) & (K Doses) Table 40. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Type (2017-2022) Table 41. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Type (2017-2022) Table 43. Global Ultra-low Molecular Weight Heparin (ULMWH) Price by Type (2017-2022) & (USD/Dose) Table 44. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses) by Application (2017-2022) Table 45. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Application (2017-2022) Table 46. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Application (2017-2022) Table 48. Global Ultra-low Molecular Weight Heparin (ULMWH) Price by Application (2017-2022) & (USD/Dose) Table 49. Hepalink Corporation Information Table 50. Hepalink Description and Business Overview Table 51. Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 52. Hepalink Ultra-low Molecular Weight Heparin (ULMWH) Product Table 53. Hepalink Recent Developments/Updates Table 54. Changshan Pharm Corporation Information Table 55. Changshan Pharm Description and Business Overview Table 56. Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 57. Changshan Pharm Ultra-low Molecular Weight Heparin (ULMWH) Product Table 58. Changshan Pharm Recent Developments/Updates Table 59. Qianhong Bio-pharma Corporation Information Table 60. Qianhong Bio-pharma Description and Business Overview Table 61. Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 62. Qianhong Bio-pharma Ultra-low Molecular Weight Heparin (ULMWH) Product Table 63. Qianhong Bio-pharma Recent Developments/Updates Table 64. Opocrin Corporation Information Table 65. Opocrin Description and Business Overview Table 66. Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 67. Opocrin Ultra-low Molecular Weight Heparin (ULMWH) Product Table 68. Opocrin Recent Developments/Updates Table 69. Pfizer Corporation Information Table 70. Pfizer Description and Business Overview Table 71. Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 72. Pfizer Ultra-low Molecular Weight Heparin (ULMWH) Product Table 73. Pfizer Recent Developments/Updates Table 74. Aspen Oss Corporation Information Table 75. Aspen Oss Description and Business Overview Table 76. Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 77. Aspen Oss Ultra-low Molecular Weight Heparin (ULMWH) Product Table 78. Aspen Oss Recent Developments/Updates Table 79. King-friend Biochemical Pharmaceutical Corporation Information Table 80. King-friend Biochemical Pharmaceutical Description and Business Overview Table 81. King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 82. King-friend Biochemical Pharmaceutical Ultra-low Molecular Weight Heparin (ULMWH) Product Table 83. King-friend Biochemical Pharmaceutical Recent Developments/Updates Table 84. Bioiberica Corporation Information Table 85. Bioiberica Description and Business Overview Table 86. Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 87. Bioiberica Ultra-low Molecular Weight Heparin (ULMWH) Product Table 88. Bioiberica Recent Developments/Updates Table 89. Dongcheng Biochemicals Corporation Information Table 90. Dongcheng Biochemicals Description and Business Overview Table 91. Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 92. Dongcheng Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Table 93. Dongcheng Biochemicals Recent Developments/Updates Table 94. Jiulong Biochemicals Corporation Information Table 95. Jiulong Biochemicals Description and Business Overview Table 96. Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 97. Jiulong Biochemicals Ultra-low Molecular Weight Heparin (ULMWH) Product Table 98. Jiulong Biochemicals Recent Developments/Updates Table 99. Tiandong Corporation Information Table 100. Tiandong Description and Business Overview Table 101. Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 102. Tiandong Ultra-low Molecular Weight Heparin (ULMWH) Product Table 103. Tiandong Recent Developments/Updates Table 104. Xinbai Corporation Information Table 105. Xinbai Description and Business Overview Table 106. Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 107. Xinbai Ultra-low Molecular Weight Heparin (ULMWH) Product Table 108. Xinbai Recent Developments/Updates Table 109. Yino Pharma Limited Corporation Information Table 110. Yino Pharma Limited Description and Business Overview Table 111. Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 112. Yino Pharma Limited Ultra-low Molecular Weight Heparin (ULMWH) Product Table 113. Yino Pharma Limited Recent Developments/Updates Table 114. Deebio Corporation Information Table 115. Deebio Description and Business Overview Table 116. Deebio Ultra-low Molecular Weight Heparin (ULMWH) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 117. Deebio Ultra-low Molecular Weight Heparin (ULMWH) Product Table 118. Deebio Recent Developments/Updates Table 119. Production Base and Market Concentration Rate of Raw Material Table 120. Key Suppliers of Raw Materials Table 121. Ultra-low Molecular Weight Heparin (ULMWH) Distributors List Table 122. Ultra-low Molecular Weight Heparin (ULMWH) Customers List Table 123. Ultra-low Molecular Weight Heparin (ULMWH) Market Trends Table 124. Ultra-low Molecular Weight Heparin (ULMWH) Market Drivers Table 125. Ultra-low Molecular Weight Heparin (ULMWH) Market Challenges Table 126. Ultra-low Molecular Weight Heparin (ULMWH) Market Restraints Table 127. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecast by Type (2023-2028) & (K Doses) Table 128. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share Forecast by Type (2023-2028) Table 129. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Forecast by Type (2023-2028) & (US$ Million) Table 130. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share Forecast by Type (2023-2028) Table 131. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecast by Application (2023-2028) & (K Doses) Table 132. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share Forecast by Application (2023-2028) Table 133. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Forecast by Application (2023-2028) & (US$ Million) Table 134. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share Forecast by Application (2023-2028) Table 135. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Forecast by Region (2023-2028) & (K Doses) Table 136. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share Forecast by Region (2023-2028) Table 137. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Forecast by Region (2023-2028) & (US$ Million) Table 138. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share Forecast by Region (2023-2028) Table 139. Research Programs/Design for This Report Table 140. Key Data Information from Secondary Sources Table 141. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ultra-low Molecular Weight Heparin (ULMWH) Figure 2. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Share by Type in 2021 & 2028 Figure 3. Oral Product Picture Figure 4. Parenteral Product Picture Figure 5. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Share by Application in 2021 & 2028 Figure 6. Treatment of Venous Thromboembolism Figure 7. Complications of Pregnancy Figure 8. Cardioversion of Atrial Fibrillation/Flutter Figure 9. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Ultra-low Molecular Weight Heparin (ULMWH) Market Size (2017-2028) & (US$ Million) Figure 11. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales (2017-2028) & (K Doses) Figure 12. Ultra-low Molecular Weight Heparin (ULMWH) Sales Share by Manufacturers in 2021 Figure 13. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Ultra-low Molecular Weight Heparin (ULMWH) Players: Market Share by Revenue in 2021 Figure 15. Ultra-low Molecular Weight Heparin (ULMWH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Region (2017-2022) Figure 17. Global Ultra-low Molecular Weight Heparin (ULMWH) Sales Market Share by Region in 2021 Figure 18. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region (2017-2022) Figure 19. Global Ultra-low Molecular Weight Heparin (ULMWH) Revenue Market Share by Region in 2021 Figure 20. U.S. Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Taiwan Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Philippines Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Vietnam Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Colombia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Ultra-low Molecular Weight Heparin (ULMWH) Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Ultra-low Molecular Weight Heparin (ULMWH) by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Ultra-low Molecular Weight Heparin (ULMWH) Figure 47. Manufacturing Process Analysis of Ultra-low Molecular Weight Heparin (ULMWH) Figure 48. Ultra-low Molecular Weight Heparin (ULMWH) Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Hepalink Changshan Pharm Qianhong Bio-pharma Opocrin Pfizer Aspen Oss King-friend Biochemical Pharmaceutical Bioiberica Dongcheng Biochemicals Jiulong Biochemicals Tiandong Xinbai Yino Pharma Limited Deebio